Furthermore, due to the high expression of epidermal growth factor receptors (EGFR) on TNBC cell membranes, modifying epidermal growth factor-peptides (EGF_Peptides) is considered an effective strategy to improve the targeting efficiency of biomimetic nanodrug delivery system to the tumor sites. This evidence concerns the gene EGFR and neoplasm.